However, truncation‐mutated GLTSCR1 loses the potential for BRD4 binding, releases RNA Pol II from the promoter‐proximal pause site to the gene body, following with an active regulation of oncogenic transcriptional elongation, which then promotes the malignant progression of CRC. This evidence concerns the gene BRD4 and colorectal carcinoma.